Cargando…

Current Practices and Gaps in Management of Dyslipidemia in Type 2 Diabetes Mellitus (T2DM) in Accordance with American Diabetes Association (ADA) Guidelines: A Subset Analysis from a Real-World, Cross-Sectional Observational Study (LEADD Study)

BACKGROUND: Diabetic dyslipidemia is a risk factor for coronary artery disease (CAD) in patients with type 2 diabetes mellitus (T2DM). American Diabetes Association (ADA) provides internationally accepted guidelines to manage dyslipidemia in T2DM. OBJECTIVE: To assess if ADA guidelines are followed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Das, Ashok Kumar, Saboo, Banshi, Unnikrishnan, Ambika G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214520/ https://www.ncbi.nlm.nih.gov/pubmed/34163197 http://dx.doi.org/10.2147/DMSO.S294842

Ejemplares similares

LEADD: Lamarckian evolutionary algorithm for de novo drug design
por: Kerstjens, Alan, et al.
Publicado: (2022)

Dyslipidemia in Pediatric Type 2 Diabetes Mellitus
por: Sunil, Bhuvana, et al.
Publicado: (2020)

Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies
por: Ray, Kausik K., et al.
Publicado: (2019)

The rule of two-thirds in diabetes epidemiology
por: Kalra, Sanjay, et al.
Publicado: (2017)

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Gujarat cohort of the A(1)chieve study
por: Saboo, Banshi, et al.
Publicado: (2013)

Key elements of successful intensive therapy in patients with type 1 diabetes
por: Saboo, Banshi
Publicado: (2015)

Saroglitazar for the treatment of hypertrig-lyceridemia in patients with type 2 diabetes: current evidence
por: Sosale, Aravind, et al.
Publicado: (2015)

Evidence-Based Consensus on Positioning of SGLT2i in Type 2 Diabetes Mellitus in Indians
por: Singh, Awadhesh Kumar, et al.
Publicado: (2019)

Expert Consensus Recommendations on Time in Range for Monitoring Glucose Levels in People with Diabetes: An Indian Perspective
por: Mohan, Viswanathan, et al.
Publicado: (2023)

Suggested use of vaccines in diabetes
por: Kesavadev, Jothydev, et al.
Publicado: (2012)

Effectiveness and safety of fixed dose combination of acarbose/metformin in Indian Type 2 diabetes patients: Results from observational GLOBE Study
por: Saboo, Banshi, et al.
Publicado: (2015)

Effective management of type 2 DM in India: Looking at low-cost adjunctive therapy
por: Aswathy, Sreedevi, et al.
Publicado: (2013)

Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature
por: Singh, Awadhesh Kumar, et al.
Publicado: (2021)

RSSDI’s Defeat Diabetes Campaign: India takes a major leap in the direction of diabetes care capital of the world
por: Saboo, Banshi, et al.
Publicado: (2021)

FRI655 Impact Of Digital Twin Intervention On Visceral Fat And Glycemic Control In T2dm With Different Levels Of Visceral Fat
por: Rameshchandra Joshi, Shashank, et al.
Publicado: (2023)

ADA’s Standards of Medical Care in Diabetes
Publicado: (2021)

Retrogression of Nervous Fibers According to the Age of Patients with Diabetes Mellitus (DM)
por: Han, Dongwook
Publicado: (2013)

RSSDI Guidelines for the management of hypertension in patients with diabetes mellitus
por: Kumar, Vasanth, et al.
Publicado: (2022)

Prevalence of dyslipidemia and associated risk factors among newly diagnosed Type-2 Diabetes Mellitus (T2DM) patients in Kushtia, Bangladesh
por: Ahmmed, Md. Saad, et al.
Publicado: (2021)

Type 2 diabetes reversal with digital twin technology-enabled precision nutrition and staging of reversal: a retrospective cohort study
por: Shamanna, Paramesh, et al.
Publicado: (2021)

RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
por: Chawla, Rajeev, et al.
Publicado: (2020)

RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
por: Chawla, Rajeev, et al.
Publicado: (2020)

Time-in-range as a target in type 2 diabetes: An urgent need
por: Saboo, Banshi, et al.
Publicado: (2021)

Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy
por: Kesavadev, Jothydev, et al.
Publicado: (2015)

Preventive pharmacotherapy in type 2 diabetes mellitus
por: Choudhary, Neeraj, et al.
Publicado: (2012)

Oxidative stress parameters and keap 1 variants in T2DM: Association with T2DM, diabetic neuropathy, diabetic retinopathy, and obesity
por: Khalili, Farnaz, et al.
Publicado: (2021)

Unproven Therapies for Diabetes and Their Implications
por: Kesavadev, Jothydev, et al.
Publicado: (2016)

Cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in India: CINDI 2
por: Sosale, Bhavana, et al.
Publicado: (2016)

Diabetes Dyslipidemia
por: Schofield, Jonathan D., et al.
Publicado: (2016)

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Davies, Melanie J., et al.
Publicado: (2018)

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Davies, Melanie J., et al.
Publicado: (2022)

Good to Know: ADA’s Standards of Medical Care in Diabetes
Publicado: (2019)

Novel pathogenic ADA2 mutations: alert to diagnosis challenge of ADA2 deficiency
por: Wu, Zhijie, et al.
Publicado: (2023)

Diabetes in India: A Dualistic Approach Beckons
por: Unnikrishnan, Ambika Gopalakrishnan
Publicado: (2021)

Characteristics and Prevalence of Latent Autoimmune Diabetes in Adults (LADA)
por: Brahmkshatriya, Priyanka P., et al.
Publicado: (2012)

Artificial Intelligence in Health Care: Focus on Diabetes Management
por: Unnikrishnan, Ambika G.
Publicado: (2019)

Treatment of dyslipidemia in patients with type 2 diabetes
por: Vijayaraghavan, Krishnaswami
Publicado: (2010)

REAL-world evidence of risk factors and comorbidities in YOUNG Indian adults with type 2 diabetes mellitus: A REAL YOUNG (diabetes) study
por: Saboo, Banshi, et al.
Publicado: (2021)

Current Indicators of Nutritional Care in Children with Type 1 Diabetes in India: Do we Need a National Nutritional Guideline?
por: Kalra, Sanjay, et al.
Publicado: (2017)

Cost of hospital treatment of type 1 diabetes (T1DM) and type 2 diabetes (T2DM) compared to the non-diabetes population: a detailed economic evaluation
por: Stedman, Mike, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_35a1mjcd32ro7nngiamobh4i3e